Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone
- Conditions
- Autistic Disorder
- Registration Number
- NCT00374764
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
Hypotheses:
1. Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment.
2. Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone.
3. Young age, cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment.
4. At baseline, children with ASDs will show significantly lower performances on measures of cognitive, neuropsychological, and socio-emotional functioning than age-matched typically developing controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- Diagnosis of autism or severe pervasive developmental disorder (PDD) not otherwise specified (NOS) according to the Autism Diagnosis Interview-Revised (ADI-R)
- Aged 2.6 to 5.0.
- Fragile X or metabolic etiology of PDD symptoms
- Diagnosis of other central nervous system (CNS) disorders
- Chronic serious medical problems
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Early Emotional Development Program
馃嚭馃嚫St. Louis, Missouri, United States